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INTRODUCTION
Endometriosis is a benign gynecologic disease de-
fined as the presence of functional endometrial
glands and stromal outside the uterine cavity. The
symptoms could be dysmenorrhea, dyspareunia,
menstrual irregularities, and infertility.1 There is
also a general agreement that endometriosis is a
pelvic inflammatory process with altered function
of immune-related cells in the peritoneal environ-
ment.2,3 Many number of studies were conducted
to support this concept, in peritoneal fluid there
were increased number of activated macrophages
that secrete various cytokines.2
The various cytokines were suggested involved
in the mechanism of progression and associated in-
fertility.4 Recently, it was reported that the level of
various cytokines is also increased in the serum of
patient with endometriosis even though there are
still debates from the conflicting result of the stud-
ies.5 From this finding, there was suggestion that
endometriosis is related to systemic subclinical in-
flammation. Furthermore, we questioned whether
those changes are significant enough to be used as
non-invasive diagnostic tools.6,7
There is a response from the body to inflamma-
tion, in which there is an increase in various plas-
ma protein, fibrinogen, haptoglobin, caeruloplas-
min and C-reactive protein (CRP).8 There are two
methods commonly used for detecting the acute
phase response-the erythrocyte sedimentation rate
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Objective: To investigate and compare serum profile of CA-125,
erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
in various stages of endometriosis.
Methods: Forty endometriosis patients’ blood samples were taken
prior to laparoscopic surgery for various indications. Diagnosis of
endometriosis was confirmed by laparoscopy. Independent T test
methods were used for statistical analysis. ROC analysis was exam-
ined for each variable.
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was 0.7 vs. 0.3 (p > 0.05) for endometriosis stage I-II and stage III-IV,
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Abstrak
Tujuan: Mengetahui dan membandingkan profil serum CA-125, Laju
endap darah (LED) dan C-reactive protein (CRP) dalam berbagai sta-
dium endometriosis.
Metode: Empat puluh pasien endometriosis diambil sampel darahnya
sebelum dilakukan operasi laparoskopi. Analisis statistik mengguna-
kan metode T tidak berpasangan. Analisis ROC diperiksa untuk setiap
variabel.
Hasil: Rerata serum CA-125 12,0 U/ml dan 36,3 U/ml (p < 0,05); se-
rum LED 11 mm/jam dan 12,8 mm/jam (p > 0,05); serum CRP 0,7 dan
0,3 (p > 0,05); masing-masing untuk stadium endometriosis I-II dan
III-IV. Titik potong optimal untuk membedakan endometriosis sta-
dium I-II dengan III-IV adalah 16,9 U/ml dengan sensitivitas 83% dan
spesifisitas 81%.
Kesimpulan: Terdapat perbedaan kadar serum CA-125 yang ber-
makna antara pasien endometriosis sedang-berat dibandingkan de-
ngan pasien endometriosis minimal-ringan.
[Maj Obstet Ginekol Indones 2012; 36-3: 121-4]
Kata kunci: CA-125, CRP, endometriosis, LED, serum
Correspondence: Sandy Prayudhana, Johnny, Department of Obstetrics and Gynecology Faculty of Medicine University of Indonesia,
Jakarta. Telephone: 081284053849 (Yudha), 08567888982 (Johnny) Email: judiojohnny@yahoo.com
Vol 36, No 3
July 2012 Moderate-severe endometriosis shows higher CA-125  121
|
(ESR) and the more specific measurement of CRP
concentration. ESR has been used since 1921, and
became popular as a non-specific screening test for
disease in the routine examination to all patients,
especially in small laboratories and primary health
clinics as it is cheap, easy to perform and does not
require a power supply nor expensive equipment.8
The gold standard for the diagnosis of endome-
triosis is laparoscopy.1,6 The severity of diseases is
categorized according to the American Fertility So-
ciety classification, which classifieds the disease
into four groups that represent minimal to severe
disease. The stage of endometriosis is positively
correlated with the degree of subfertility, but not
with the degree of pelvic pain.
Development of a noninvasive diagnostic test for
endometriosis would have a ground breaking affect
on patient’s quality of life, on the efficacy of avail-
able treatment, and on the cost of endometriosis.5,7
Many serum biomarkers were proposed for further
study. One of the biomarker is CA-125, which have
been researched for almost three decades. Serum
CA-125 measurement is now a consolidated me-
thod for diagnosing this condition and almost rou-
tinely measured in endometriosis patient. How-
ever, its interpretation has posed a number of pro-
blems, particularly regarding its use in diagnosing
minimal and mild endometriosis, whereas its value
as a diagnostic aid in moderate-severe stages is
well recognized.
The purpose of this study was to see the profile
of preoperative CA-125, ESR and CRP serum values
in surgically treated endometriosis patient for vari-
ous indication.
METHOD
From January to April 2012, we collected 40 pa-
tients who underwent laparoscopic surgery for en-
dometriosis at Bunda hospital and YPK hospital,
Jakarta. The diagnosis was made intraoperative
based on the finding of endometriosis lesion or en-
dometrioma. Informed consent from the patients
was obtained, and the ethical review board of Uni-
versity Indonesia approved the study. We collected
the obstetric and gynecologic history and relevant
medical history, clinical symptoms, preoperative
serum CA-125, ESR and CRP levels. The assay CA-
125, ESR and CRP levels were performed at least
1 day before surgery. The serum CA-125 was mea-
sured by chemiluminescent immunoassay by advia
centaur; serum CRP was measured by immunotur-
bidimetrybycobasintegra; while ESR was measured
manually with SRS 20. We used independent T test
to detecting difference in mean serum CA-125 , ESR
and CRP. We performed receiver operating charac-
teristic (ROC) curve analysis to assess the clinical
utility of serum biomarker in distinguishing se-
vere-moderate and minimal mild patient. The cut-
off values derived from ROC curves were evaluated
in terms of sensitivity and specificity.
RESULT
There were 40 subjects in this study that were clas-
sified according to the Revised American Study for
Reproductive Medicine endometriosis classificati-
on. Twenty six subjects had minimal-mild and four-
teen subjects had moderate-severe endometriosis.
The distribution of age, BMI, and smoking in both
group are similar. Minimal-mild endometriosis
subjects had 88% infertility compared to 57% in
moderate-severe subjects.
Table 1. Subject Characteristics
Variable Minimal-Mild(n=26)
Moderate-Severe
(n=14)
Age (year)   34.1   30.3
BMI
Normal (18.5-24.9) 24 11
High (≥ 25)  2  3
Smoking
Yes  2  2
No 24 12
Infertility
Yes 23  8
No  3  6
Parity
0 23 12
1  2  1
≥ 2  1  1
The level of serum ESR, CRP and CA-125 did not
have normal distribution. We transform the data
into logarithmic to have normal distribution for in-
dependent T test calculation. Serum CA-125 could
discriminate endometriosis stage I-II from stage
III-IV with mean level 12.0 vs. 36.3 U/ml respec-
tively (p=0.000). No difference was found for se-
rum level ESR and CRP.
Indones J
122  Prayudhana et al Obstet Gynecol
|
Serum CA-125 had AUC 87% (p < 0.001), mean-
while for serum ESR and CRP were 58% (p =
0.497) and 29% (p = 0.161) respectively. From the
ROC curve analysis, we acquired that the optimal
cut off point for serum level CA-125 to differentiate
endometriosis stage I-II and III-IV was 16.9 U/ml.
It has sensitivity 83% and specificity 81%. If the
cut off point of CA-125 was >35 U/ml, the sensi-
tivity was 67% and specificity 90%.
DISCUSSION
Women with endometriosis have been found to
have elevated CA-125 levels in their serum, men-
strual blood, and peritoneal fluid. However, the CA-
125 level is not specific to endometriosis.
This study demonstrates that preoperative CA-
125 assay is useful to distinguish high-risk from
low-risk endometriosis patients. Our results indi-
cate a new use for preoperative serum CA-125 ex-
amination in addition to the diagnosis of endome-
triosis. The results confirm previous reports that
preoperative CA-125 levels increase with the sta-
ges of endometriosis.9 It further extends the obser-
vations that omentum adhesion and rupture of en-
dometrioma are also the leading causes of elevated
CA-125 levels.9 Our study acquired a sensitivity of
83% and specificity of 81% for 16.9 U/ml as the
optimal cut off point for CA-125. Silva et al got a
slightly different cut-off point of 20 U/ml with
44.7% sensitivity and 92.2% specificity.10 Cheng
stated that CA-125 level was significantly higher in
Table 2. Bivariate analysis between ESR, CRP, and CA-125 with the severity of endometriosis.
Variable GM
a
SEM p fromΔ Mean
GM ratiob
(95% CI) AUC (95% CI)
p from
AUC
ESR (mm/hr)
Std I-II 11.0 6.6 0.541 1.1 (0.5-1.4) 0.58 (0.35-0.81) 0.497
Std III-IV 12.8 5.2
CRP
Std I-II 0.7 1.3 0.194 0.4 (0.6-7.3) 0.29 (0.02-0.57) 0.161
Std III-IV 0.3 1.5
CA-125 (U/ml)
Std I-II 12.0 4.6 0.000 3.0 (0.1-0.5) 0.87 (0.74-1.00) < 0.001
Std III-IV 36.3 1.2
a Mean was shown as Geometric Mean (GM)
b Geometric mean ratio was used to shown the difference of geometric mean
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Figure 1. AUC graphic from (A) ESR, (B) CRP, and (C) CA-125 with ROC methods.
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advanced stages.10 Furthermore, serum CA-125 le-
vels were significantly higher in patients with more
extensive adhesions of the peritoneum, omentum,
ovary, fallopian tube, colon, and cul-de-sac, or with
ruptured endometrioma. Several authors claimed
that its combination with transvaginal ultrasono-
graphy may help the differentiation of endome-
trioma from other benign ovarian cysts.9 Patrelli
stated that there was a relationship between the
serum CA-125 values and the location of endome-
triosis foci, with higher elevations in ovarian and
mixed forms than in extraovarian forms.11
Although the pathogenesis of endometriosis is
still controversial, growing evidence indicate a sig-
nificant role of inflammatory factors involved in
the development of endometriosis.12,13 Biomarker
such as CRP and ESR are acute phase proteins that
increased when inflammation occurs. It has been
suggested that in women with endometriosis there
is an inflammatory reaction of the pelvic peritone-
um. Inflammation, as a local response to tissue in-
jury, results in changes of vascular caliber, flow,
and increased vascular permeability. The increas-
ing level of CRP and ESR in pelvic peritoneum due
to inflammation process can also be detected in
blood serum.12 However, measurement of CRP and
ESR from our research did not appear to be advan-
tageous for determining the severity of endome-
triosis. There was no association between CRP
level and stage of the disease. Vodolazkaia reported
different finding; he found statistically significant
different median of CRP level between stage I-II
and stage III-IV of endometriosis.
CONCLUSION
The CA-125 serum level was increased for mode-
rate-severe endometriosis compared to minimal
and mild endometriosis patient. The optimal cut off
point for serum level CA-125 to differentiate bet-
ween endometriosis stage I-II and III-IV is 16.9
U/ml, with 83% sensitivity and 81% specificity.
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